| 薛世民 蒋伟 贾娟 张王锋 吴桂莲.莫西沙星治疗老年支原体肺炎患者的临床疗效分析[J].,2016,16(18):3551-3554 |
| 莫西沙星治疗老年支原体肺炎患者的临床疗效分析 |
| Analysis of the Curative Effect of Moxifloxacin on Senile Patients withMycoplasma Pneumonia |
| |
| DOI： |
| 中文关键词: 莫西沙星 支原体肺炎 白细胞计数 C 反应蛋白 |
| 英文关键词: Moxifloxacin Mycoplasma Pneumonia WBC CPR |
| 基金项目:陕西省自然科学基金项目（20130115S） |
|
| 摘要点击次数: 515 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：探讨莫西沙星治疗老年支原体肺炎患者的临床疗效。方法：收集我院收治的老年支原体肺炎患者80 例，年龄60~79
岁，随机分为对照组和实验组，每组各40 例，两组患者均给予相应常规对症治疗，对照组患者给予红霉素治疗；实验组患者给予
莫西沙星治疗。治疗结束后，比较两组患者的退热时间、住院时间、白细胞计数、C 反应蛋白水平以及患者的临床总有效率。结果：
与治疗前相比，两组患者治疗后的白细胞计数、C反应蛋白水平均显著下降(P<0.05)，且实验组患者退热时间以及住院时间较对照
组显著缩短(P<0.05)，白细胞计数、C 反应蛋白水平明显低于对照组(P<0.05)，而临床治疗总显著高于对照组(P<0.05)。结论：莫西沙
星能显著提高老年支原体肺炎患者的临床疗效。 |
| 英文摘要: |
| Objective:To investigate the clinical efficacy of moxifloxacin in the treatment of elderly patients with mycoplasma pneumonia.Methods:80 elderly patients with Mycoplasma Pneumonia who were admitted in our hospital were randomly divided into the
control group and the experimental group, with 40 cases in each group, and all the patients were treated with the conventional
symptomatic methods. Besides, the control group was treated with erythromycin, while the experimental group was given moxifloxacin.
At the end of treatment, the fever, hospitalization time, WBC count, CRP levels and clinical total efficiency Were compared between two
groups.Results:Compared with before treatment, the WBC counts and CRP levels of both groups after treatment were significantly
decreased (P<0.05), and the antipyretic time and hospitalization time of experimental group were significantly shorter than those of the
control group (P<0.05), and the WBC count and CRP levels were significantly lower than the control group (P<0.05), while the clinical
efficacy was significantly higher than that of the control group (P<0.05).Conclusion:Moxifloxacin could significantly improve the
clinical efficacy of elderly patients with Mycoplasma Pneumonia. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
